- Home
- ZNTL vs ONL Comparison
ZNTL vs ONL Comparison
Compare ZNTL & ONL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZNTL
- ONL
- Stock Information
- Founded
- ZNTL 2014
- ONL 2021
- Country
- ZNTL United States
- ONL United States
- Employees
- ZNTL N/A
- ONL N/A
- Industry
- ZNTL Biotechnology: Pharmaceutical Preparations
- ONL Real Estate Investment Trusts
- Sector
- ZNTL Health Care
- ONL Real Estate
- Exchange
- ZNTL Nasdaq
- ONL Nasdaq
- Market Cap
- ZNTL 105.8M
- ONL 119.7M
- IPO Year
- ZNTL 2020
- ONL N/A
- Fundamental
- Price
- ZNTL $1.34
- ONL $2.59
- Analyst Decision
- ZNTL Buy
- ONL Hold
- Analyst Count
- ZNTL 7
- ONL 1
- Target Price
- ZNTL $8.60
- ONL N/A
- AVG Volume (30 Days)
- ZNTL 772.3K
- ONL 392.6K
- Earning Date
- ZNTL 08-12-2025
- ONL 08-06-2025
- Dividend Yield
- ZNTL N/A
- ONL 3.05%
- EPS Growth
- ZNTL N/A
- ONL N/A
- EPS
- ZNTL N/A
- ONL N/A
- Revenue
- ZNTL $26,865,000.00
- ONL $154,796,000.00
- Revenue This Year
- ZNTL N/A
- ONL N/A
- Revenue Next Year
- ZNTL N/A
- ONL N/A
- P/E Ratio
- ZNTL N/A
- ONL N/A
- Revenue Growth
- ZNTL N/A
- ONL N/A
- 52 Week Low
- ZNTL $1.01
- ONL $1.46
- 52 Week High
- ZNTL $5.44
- ONL $4.39
- Technical
- Relative Strength Index (RSI)
- ZNTL 46.92
- ONL 57.97
- Support Level
- ZNTL $1.34
- ONL $2.58
- Resistance Level
- ZNTL $1.48
- ONL $2.70
- Average True Range (ATR)
- ZNTL 0.08
- ONL 0.12
- MACD
- ZNTL -0.01
- ONL -0.01
- Stochastic Oscillator
- ZNTL 21.74
- ONL 58.62
About ZNTL Zentalis Pharmaceuticals Inc.
Zentalis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing azenosertib (ZN-c3), a potentially first-in-class and best-in-class WEE1 inhibitor for patients with Cyclin E1-positive platinum-resistant ovarian cancer (Cyclin E1+ PROC). The Company manages its operations as a single segment for the purposes of assessing performance and making operating decisions.
About ONL Orion Office REIT Inc.
Orion Properties Inc is a internally-managed REIT engaged in the ownership, acquisition, and management of a diversified portfolio of mission-critical and headquarters office buildings located in high quality suburban markets across the U.S. and leased on a single-tenant net lease basis to creditworthy clients. The portfolio of the company includes traditional office buildings, governmental offices, medical offices, laboratories, and others. The Company operates in one business segment: direct ownership and operation of commercial real estate.